To prevent chemotherapy-induced febrile neutropenia, G-CSF was added to chemotherapy regimen and chemotherapy with PEGylated filgrastim yielded favorable clinical outcomes in breast cancer patients24,25. This evidence concerns the gene CSF3 and breast carcinoma.